NASDAQ:RNW
ReNew Energy Global PLC Surpasses Earnings Estimates in Renewable Sector
Font: Financial Modeling Prep • Jun 16, 2025
ReNew Energy Global PLC's Financial Performance and Strategic Growth in the Renewable Energy Sector
ReNew Energy Global PLC (NASDAQ:RNW) reported earnings per share of $0.10 for its last quarter, surpassing estimates of $0.07. The company's revenue reached approximately $403 million, exceeding expectations and reflecting robust strategic growth. Despite high valuation and debt metrics, RNW's financial success underscores its advancements in the renewable energy sector.
ReNew Energy Global PLC, trading on NASDAQ under the symbol RNW, is a leading player in the renewable energy sector, focusing on clean energy generation through wind, solar, and hydroelectric power. It competes with firms like NextEra Energy and Brookfield Renewable Partners. RNW's recent earnings report highlights its strong financial performance and strategic progress.
On June 16, 2025, RNW reported earnings per share of $0.10, significantly outperforming the Zacks Consensus Estimate of $0.07 and improving from the previous year's $0.02 per share. This achievement demonstrates the company's ability to exceed market expectations.
RNW's revenue for the quarter was approximately $403 million, surpassing projections and aligning with the company's reported fourfold increase in net profit for the fourth quarter, as noted by Business Wire. This revenue growth reinforces RNW's strategic advancements in the renewable energy sector.
Despite its strong earnings, RNW faces financial challenges. The company has a high price-to-earnings (P/E) ratio of 725.66, indicating a lofty valuation relative to its earnings. Its debt-to-equity ratio of 6.80 suggests significant debt compared to equity, posing potential financial risks. Additionally, RNW's current ratio of 0.60 may signal liquidity challenges in meeting short-term obligations. However, the company's enterprise value to sales ratio of 10.69 and enterprise value to operating cash flow ratio of 13.93 reflect its valuation relative to sales and cash flow. Despite a low earnings yield of 0.14%, RNW's strategic growth in the renewable energy sector remains compelling.
Market Overview
|
VRAX
Virax Biolabs Group Limited
|
$0.24
53.09%
|
|
WGRX
Wellgistics Health, Inc.
|
$0.17
108.38%
|
|
AIM
AIM ImmunoTech Inc.
|
$0.41
61.26%
|
|
SBFM
Sunshine Biopharma, Inc.
|
$0.51
79.51%
|
|
SOXS
Direxion Daily Semiconductor Bear 3X ETF
|
$9.95
7.80%
|
|
TZA
Direxion Daily Small Cap Bear 3X ETF
|
$5.05
1.81%
|
|
PMI
Picard Medical, Inc.
|
$0.17
7.06%
|
|
GOVX
GeoVax Labs, Inc.
|
$2.21
79.67%
|
|
NXXT
NextNRG Inc.
|
$0.41
46.22%
|
|
CREG
Smart Powerr Corp.
|
$0.62
30.59%
|
